Entera Bio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Entera Bio Ltd. (ENTX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-9.54-8.89-13.07-12.19-11.22-8.92-10.30
Depreciation & Amortization0.050.060.060.050.060.000.05
Deferred Income Tax0.010.030.17-0.220.000.000.00
Stock Based Compensation2.561.692.251.860.900.000.00
Change in Working Capital0.11-0.20-1.841.41-0.354.00-0.51
Change in Accounts Receivable-0.130.25-0.060.070.020.000.00
Change in Accounts Payable0.050.07-0.150.00-0.170.000.00
Change in Other Working Capital0.19-0.51-1.610.02-0.100.000.00
Other Operating Activities0.010.030.100.020.950.000.29
Net Cash from Operating Activities-6.82-7.31-12.50-9.06-10.56-8.92-9.80
Investing Activities
Capital Expenditures0.00-0.02-0.05-0.020.050.04-0.07
Sales/Maturities of Investments0.000.000.000.000.000.00-4.00
Other Investing Activities0.000.00-0.060.000.000.000.00
Net Cash from Investing Activities0.00-0.02-0.10-0.02-0.053.95-4.07
Financing Activities
Debt Repayment0.00-0.580.000.00-0.14-0.110.00
Common Stock Issued4.806.620.0121.813.190.009.62
Other Financing Activities-0.32-0.580.003.580.070.000.00
Net Cash from Financing Activities4.486.040.0125.384.0512.659.62
Summary
Net Change in Cash-2.35-1.29-12.5916.30-6.567.68-4.24
Cash at Beginning of Period11.0912.3824.968.6615.227.5111.75
Cash at End of Period8.7411.0912.3824.968.6615.197.51
Free Cash Flow-6.82-7.33-12.55-9.08-10.61-8.96-9.86
Supplemental Disclosures
Income Taxes Paid0.000.000.170.000.090.000.00